This guideline is designed primarily as an educational resource for healthcare providers to help them provide quality medical genetic services. Adherence to this guideline does not necessarily assure a successful medical outcome. This guideline should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, the geneticist should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen. It may be prudent, however, to document in the patient's record the rationale for any significant deviation from this guideline.

There is no clearly accepted definition of advanced paternal age. A frequently used criterion is any man aged 40 years or older at the time of conception. The current population mean paternal age is 27 years.

Advanced paternal age is associated with an increased risk of new gene mutations. Because of the large number of cell divisions during spermatogenesis, the mutation rate for base substitutions is much higher in men than women, and increases with paternal age. The risk for genetic defects increases linearly for some conditions, and exponentially for others.[@b1-18496227]--[@b3-18496227] The conditions most strongly associated with advanced paternal age are those caused by mutations in the form of single base substitutions in the *FGFR*2, *FGFR*3, and *RET* genes, and include Pfeiffer syndrome, Crouzon syndrome, Apert syndrome, achondroplasia, thanatophoric dysplasia, as well as MEN2A and MEN2B.[@b4-18496227] Some dominant conditions that are caused by gene changes that include both point mutations and base pair deletions (e.g., neurofibromatosis) show a lesser association with paternal age. Other dominant conditions show no association with increased paternal age.[@b5-18496227] Although Friedman[@b6-18496227] had estimated that the risk for autosomal dominant disorders affecting offspring of fathers aged 40 or more was 0.3--0.5%, it is now thought that the actual risk is lower.[@b7-18496227] There is also a growing body of evidence that advanced paternal age is associated with an increased risk for complex disorders such as some congenital anomalies, schizophrenia, autism spectrum disorders, and some forms of cancer.[@b8-18496227] --[@b12-18496227] For most conditions the relative risk is two or less. However, the mechanism for the increased risk is unknown, and in some cases, the observed paternal age effect may be an artifact of some other causative factor.

In general, for autosomes and sex chromosomes, there is no compelling evidence that chromosomal aberrations (aneuploidy or structural chromosome abnormalities) are significantly increased in newborns as paternal age increases. The low incidence of paternally derived extra chromosomes in trisomies combined with the relatively small number of children fathered by older men makes it difficult to demonstrate a paternal age effect. Two possible exceptions are trisomy 21 and Klinefelter syndrome. Recent data on Down syndrome suggest a paternal age effect, either acting alone or in combination with a maternal age effect.[@b13-18496227],[@b14-18496227] This observation is supported by reports of increased aneuploidy rates in sperm for some of the chromosomes, including 21 and the sex chromosomes.[@b15-18496227]--[@b17-18496227] In summary, there is a wide range of genetic disorders that may be related to advanced paternal age ([Table 1](#t1-18496227){ref-type="table"}). Overall, it seems that the risk of birth defects and some chromosome disorders may be minimally increased, and the risk for later onset disorders may also show a small increase with advanced paternal age. There are currently no screening or diagnostic test panels which specifically target those conditions that increase with paternal age. If the older male's partner is currently pregnant, the pregnancy should be treated as any other according to prenatal diagnosis guidelines established by the American College of Medical Genetics and American College of Obstetricians and Gynecologists,[@b18-18496227]--[@b20-18496227] with the prenatal counseling session including a discussion about the potentially increased risk of Down syndrome attributable to increased paternal age. Because of this and the possibility of ultrasound detection of some of the features of the autosomal dominant conditions noted above (e.g., thanatophoric dysplasia), an ultrasound is recommended at 18--20-weeks gestation to evaluate fetal growth and development. However, it is unlikely to detect many of the conditions of interest. Prospective couples should receive individualized genetic counseling to address specific concerns.
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Paternal age risks

  Type                      Specific condition                     Age (relative to reference age)   Relative risk (CI, if available)                                       Population risk (or reference risk)                                                                Adjusted risk        References (first author's name only)
  ------------------------- -------------------------------------- --------------------------------- ---------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- -------------------- ----------------------------------------------
  Autosomal dominant        Achondroplasia                         \>50 (25--29)                     7.8                                                                    1/15,000                                                                                           1/1923               Risch[@b1-18496227]
                                                                   30--34 (\<20)                     3.5                                                                                                                                                                       1/4285               Tiemann-Boege[@b21-18496227]
                                                                   35--39 (\<20)                     4                                                                                                                                                                         1/3750               
                                                                   40--44 (\<20)                     8                                                                                                                                                                         1/1875               
                                                                   45--49 (\<20)                     9                                                                                                                                                                         1/1666               
                                                                   50--54 (\<20)                     12                                                                                                                                                                        1/1250               
                            Apert                                  \>50 (25--29)                     9.5                                                                    1/50,000                                                                                           1/5263               Risch[@b1-18496227]
                            Pfeiffer                               \>50 (25--29)                     6                                                                      1/100,000                                                                                          1/16,666             Glaser[@b22-18496227]
                            Crouzon                                \>50 (25--29)                     8                                                                      1/50,000                                                                                           1/6250               
                            Progeria                               Unknown                           Effect seen                                                            "Exceedingly rare"                                                                                                      
                            MEN2A                                  Unknown                           Effect seen                                                            1/30,000                                                                                                                
                            MEN2B                                  Unknown                           Effect seen                                                            1/30,000                                                                                                                
                            Neurofibromatosis I                    \>50 (25--29)                     3.7*[^a^](#tfn2-18496227){ref-type="table-fn"}*                        1/3000--1/4000                                                                                     1/810--1/1080        Risch[@b1-18496227]
                                                                   \>40 (\<30)                       2.9                                                                                                                                                                       1/1034--1/1380       Bunin[@b23-18496227]
                            Osteogenesis imperfecta                \>35 (\<25)                       2.5                                                                    1/10,000                                                                                           1/4000               Carothers[@b24-18496227]
                                                                   \>35 (\<35)                       1.37 (0.73--6.89)                                                                                                                                                         1/7300               Orioli[@b25-18496227]
                            Thanatophoric dysplasia                \>35 (\<35)                       3.18 (1.48--6.89)                                                      1/20,000--1/50,000                                                                                 1/6290--1/15,723     Orioli[@b25-18496227]
                            Retinoblastoma                         \>45                              3*[^a^](#tfn2-18496227){ref-type="table-fn"}* (0.21--41.7)             1/15,000--1/20,000                                                                                 1/5000--1/6667       Dockerty, Yip[@b26-18496227],[@b27-18496227]
                                                                   \>35 (\<35)                       1.34 (1.04--1.74)                                                                                                                                                         1/11,200--1/14,925   Moll[@b28-18496227]
                                                                   \>50 (32.5)                       5                                                                                                                                                                         1/3000--1/4000       DerKinderen[@b29-18496227]
  Chromosomal               Down syndrome                          40--44 (20--29)                   1.37 (0.48--3.86)                                                      1/1200 (mat. age 20--29)                                                                           1/876                Zhu[@b30-18496227]
                                                                   45--49 (20--29)                   2.68 (0.76--9.51)                                                                                                                                                         1/448                
                                                                   \>49 (20--29)                     4.5 (1.0--20.3)                                                                                                                                                           1/267                
                                                                   40--44 (25--29)                   1.45 (1.26--1.68)                                                      Use maternal age as baseline for counseling purposes*[^b^](#tfn3-18496227){ref-type="table-fn"}*                        Yang[@b31-18496227]
                                                                   45--49 (25--29)                   1.28 (1.04--1.57)                                                                                                                                                                              
                                                                   \>49 (25--29)                     1.39 (1.04--1.83)                                                                                                                                                                              
                                                                   None given                        "May be increased"                                                                                                                                                                             Kuhnert[@b16-18496227]
                                                                   None given                        "Paternal age effect in association with maternal age (\>35) effect"                                                                                                                           Fisch[@b14-18496227]
                            Klinefelter syndrome                   \>50 (20's)                       1.6*[^c^](#tfn4-18496227){ref-type="table-fn"}* (0.69--3.0)            1/500 men                                                                                          1/312 men            Lowe[@b32-18496227]
  Congenital anomalies      VSD                                    \>40 (\<40)                       1.69*[^a^](#tfn2-18496227){ref-type="table-fn"}*                       1/200                                                                                              1/118                Olshan[@b33-18496227]
                            ASD                                    \>35                              1.95*[^a^](#tfn2-18496227){ref-type="table-fn"}*                       1/400                                                                                              1/205                Lian[@b11-18496227]
                            Tracheoesophageal fistula              \>50 (25--29)                     2.55 (1.28--4.6)                                                       1/3600                                                                                             1/1412               Yang[@b31-18496227]
  Other complex disorders   Childhood leukemia                     \>35                              1.5                                                                    1/25,000                                                                                           1/16,667             Murray[@b34-18496227]
                                                                   \>40 (\<25)                       1.14 (0.85--1.53)                                                                                                                                                         1/21930              Yip[@b27-18496227]
                            Childhood CNS tumor                    30--34 (\<25)                     1.34 (1.04--1.72)                                                      1/36,000                                                                                           1/26,866             Yip[@b27-18496227]
                                                                   35--39 (\<25)                     1.4 (1.04--1.86)                                                                                                                                                          1/25,714             
                                                                   \>40 (\<25)                       1.69 (1.21--2.35)                                                                                                                                                         1/21,302             
                            Childhood type 1 diabetes              \>34 (\<25)                       1.52 (1.1--2.09)                                                       1/415                                                                                              1/273                Cardwell[@b35-18496227]
                            Epilepsy                               35--39                            1.18 (1.02--1.26)                                                      1/100                                                                                              1/85                 Vestergaard[@b36-18496227]
                                                                   40--45                            1.3 (1.08--1.55)                                                                                                                                                          1/770                
                            Schizophrenia                          \>50 (20--24)                     4.62 (2.28--9.36)                                                      1/100                                                                                              1/22                 Rasmussen[@b37-18496227]
                                                                   35--44 (15--24)                   1.6 (1.0--2.6)                                                                                                                                                            1/62.5               Zammit[@b38-18496227]
                                                                   45--54 (15--24)                   1.6 (0.8--3.1)                                                                                                                                                            1/62.5               
                                                                   \>54 (15--24)                     3.8 (1.3--11.8)                                                                                                                                                           1/26                 
                                                                   \>49 (\<25)                       3                                                                                                                                                                         1/33                 Malaspina[@b12-18496227]
                                                                   \>32 (\<28)                       3 (1.49--6.04)                                                                                                                                                            1/33                 Tsuchiya[@b39-18496227]
                            Autism                                 \>40 (\<30)                       5.75 (2.65--12.46)                                                     1/1000                                                                                             1/174                Reichenberg[@b40-18496227]
                                                                   Unknown                           Effect seen                                                                                                                                                                                    Cantor[@b9-18496227]
                            Autism spectrum disorders              35--39 (25--29)                   1.38 (1.04--1.84)                                                      1/200                                                                                              1/145                Croen[@b41-18496227]
                                                                   \>39 (25--29)                     1.52 (1.1--2.1)                                                                                                                                                           1/131                
                            Breast cancer                          \>40 (\<30)                       1.6 (1.04--2.32)                                                       1/8.5                                                                                              1/5.3                Choi[@b42-18496227]
                            Prostate cancer                        \>38 (\<27)                       1.7 (1.0--2.8)                                                         1/5.9                                                                                              1/3.5                Zhang[@b43-18496227]
                            Multiple sclerosis                     51--55 (21--25)                   2.0 (1.35--2.96)                                                                                                                                                                               Montgomery[@b44-18496227]
  Other                     Spontaneous miscarriages               \>35 (\<35)                       1.26 (1.0--1.6)                                                        1/7                                                                                                1/5.3                Slama[@b45-18496227]
                                                                   \>39 (25--29)                     1.6 (1.2--2.0)                                                                                                                                                            1/4                  Kleinhaus[@b46-18496227]
                            Relative infertility                   \>39 (\<39)                       2.3 (1.67--3.17)                                                       1/14 couples                                                                                       1/6.2                De la Rochebrochard[@b47-18496227]
                            Low birth weight                       \>34 (20--34)                     1.7 (1.3--2.2)                                                         1/40                                                                                               1/23                 Reichman[@b48-18496227]
                            Preeclampsia                           35--44 (25--34)                   1.24 (1.05--1.46)                                                      1/62                                                                                               1/50                 Harlap[@b49-18496227]
                                                                   \>44 (25--34)                     1.8 (1.04--1.51)                                                       1/62                                                                                               1/34                 
  Total risk                For 86 examined congenital anomalies   \>40 (\<20)                       1.2                                                                    1/50                                                                                               1/42                 Lian[@b11-18496227]
                            \>50 (\<20)                            1.3                                                                                                      1/38                                                                                                                    

This table is meant to show the findings of various studies examining the effect of paternal age on the condition in question. It is not meant to be a comprehensive guide to counseling, but to merely indicate conditions which have been studied and results obtained from those studies.

Increased risk not shown by other studies.

Suggestion for this adjustment made by the author of this document. There are no data regarding use of paternal age for counseling for serum screening results.

Based on frequency of XY sperm.

[^1]: Helga V. Toriello, PhD, Genetics Services, Spectrum Health, 21 Michigan St, Ste 465, Grand Rapids, MI 49503-2528. E-mail: <helga.toriello@spectrum-health.org>.
